Table 2 Outcome data from the COURAGE, BARI, and BARI 2D Trials [16–18]
From: Treatment of specific macrovascular beds in patients with diabetes mellitus
Trial | Outcome | PCI | CABG | MT |
|---|---|---|---|---|
COURAGE | Death from any cause/nonfatal MI* | 19% | Â | 18.5% |
| Â | Angina free status | 74% | Â | 72% |
BARI | Survival* | 71% | 73.5% | Â |
| Â | Survival (Diabetes subgroup) | 45.5% | 57.8% | Â |
BARI 2D | Survival* | 88.3% | 87.8% | |